Cargando…
Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India – Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1
PURPOSE: COVID-19-associated rhino-orbital-cerebral mucormycosis (ROCM) has reached epidemic proportion during India’s second wave of COVID-19 pandemic, with several risk factors being implicated in its pathogenesis. This study aimed to determine the patient demographics, risk factors including como...
Ejemplares similares
-
Orbital Mucormycosis: Understanding the Deadly Fungus Sweeping the Globe
por: Farooq, Shaheen, et al.
Publicado: (2023) -
Transcutaneous retrobulbar amphotericin-B (TRAMB) injection in orbital mucormycosis
por: Singh, Prabhakar, et al.
Publicado: (2022) -
Epidemic of Mucormycosis in COVID-19 Pandemic: A Position Paper
por: Kulkarni, Rahul, et al.
Publicado: (2022) -
COVID-19-Associated Pulmonary Mucormycosis
por: Krishna, Vidya, et al.
Publicado: (2022) -
Automatic detection of osteosarcoma based on integrated features and feature selection using binary arithmetic optimization algorithm
por: Bansal, Priti, et al.
Publicado: (2022)